Inspire Medical Systems (INSP) Cash from Investing Activities (2017 - 2026)

Inspire Medical Systems (INSP) has 10 years of Cash from Investing Activities data on file, last reported at -$11.2 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Investing Activities fell 624.34% year-over-year to -$11.2 million; the trailing twelve-month figure through Mar 2026 stood at $11.8 million (up 112.35% YoY), and the FY2025 full-year result was $21.4 million, up 118.96% from the prior year.
• Cash from Investing Activities improved to -$11.2 million in Q1 2026, from -$11.9 million in the prior quarter.
• In the past five years, Cash from Investing Activities ranged from a high of $46.6 million in Q2 2025 to a low of -$151.7 million in Q4 2023.
• A 5-year average of -$24.5 million and a median of -$3.8 million in 2022 frame the typical range for Cash from Investing Activities.
• Across the five-year window, Cash from Investing Activities slumped 5043.15% in 2023 and soared 728.51% in 2025, its largest moves.
• Tracing INSP's Cash from Investing Activities over 5 years: stood at -$2.9 million in 2022, then tumbled by 5043.15% to -$151.7 million in 2023, then jumped by 102.48% to $3.8 million in 2024, then plunged by 416.88% to -$11.9 million in 2025, then increased by 5.61% to -$11.2 million in 2026.
• Business Quant data shows INSP's Cash from Investing Activities at -$11.2 million in Q1 2026, -$11.9 million in Q4 2025, and -$11.6 million in Q3 2025.